Results 221 to 230 of about 127,688 (268)

Photographic scoring of gingival overgrowth

Journal of Clinical Periodontology, 2001
AbstractBackground: A wide range of methods have been employed to determine the severity of gingival overgrowth resulting in uncertainty regarding the prevalence of the side‐effect. There is no simple, non‐invasive, objective, blind method for assessing gingival overgrowth.Aim: This article aims to describe a method which is suitable for use in large ...
J S, Ellis, R A, Seymour, P, Robertson, T J, Butler, J M, Thomason   +4 more
openaire   +3 more sources

Gingival overgrowth secondary to amlodipine

British Journal of Hospital Medicine, 2009
A 66-year-old Asian woman attended for optimization of blood pressure control. Prescribed medication included atenolol (50 mg once daily), bendrofluazide (2.5 mg once daily) and amlodipine (5 mg once daily). She complained of gingival overgrowth, occurring several months after starting amlodipine (Figure 1).
Simon W, Dubrey, Richard, Grocott-Mason
openaire   +2 more sources

Cyclosporine and gingival overgrowth

Journal of Oral Pathology & Medicine, 1987
A case of cyclosporine‐induced gingival overgrowth is presented. Overgrown and inflamed gingivae were noted at several sites in the mouth of a patient taking Cyclosporine following a renal transplant. These were associated with areas adjacent to heavy plaque and calculus deposits on the teeth.
openaire   +2 more sources

Elevated Interleukin-17A expression in amlodipine-induced gingival overgrowth.

Journal of Periodontal Research, 2020
BACKGROUND AND OBJECTIVES Amlodipine, a calcium channel blocker derivative, is frequently used by patients with high blood pressure. Studies reported that it can induce gingival overgrowth.
S. S. Sume, E. Berker, Y. İlarslan, Ozlem Ozer Yucel, Çağman Tan, Samir Goyusov, S. E. Gultekin, I. Tezcan   +7 more
semanticscholar   +1 more source

The gingival crevicular fluid levels of growth factors in patients with amlodipine-induced gingival overgrowth: A pilot study

Nigerian Journal of Clinical Practice, 2020
Background: Amlodipine, calcium channel blocker (CCB), is used in the management of cardiovascular diseases which causes gingival overgrowth (GO). The growth factors may have a role in the pathogenesis of amlodipine-induced GO.
K. N. Köse, S. Yılmaz, Ülkü Noyan, B. Kuru, H. Yildirim, Ö. Ağralı, Hafize Öztürk Özener, L. Kuru   +7 more
semanticscholar   +1 more source

Role of IL-6 and STAT3 signaling in dihydropyridine-induced gingival overgrowth fibroblasts.

Oral Diseases, 2020
OBJECTIVES This study analyzed the role of the interleukin (IL)-6/signal transducer and activator of transcription 3 (STAT3) pathway in dihydropyridine-induced gingival overgrowth (DIGO) fibroblasts.
Sao-Lun Lu, Chiung-Fang Huang, Chuan-Li Li, Hsein-Kun Lu, Li-Sheng Chen   +4 more
semanticscholar   +1 more source

Gingival overgrowth

2012
2, 19, Journal of Medicine and Health ...
openaire   +1 more source

Iatrogenic Gingival Overgrowth in Cardiac Transplantation

Journal of Periodontology, 1995
It is well established that both cyclosporin and nifedipine are associated with gingival overgrowth. Although both drugs are widely used in the management of organ transplant patients, there is little information on the prevalence and severity of this unwanted effect in cardiac transplant patients. This study evaluated the gingival health of 94 dentate
J M, Thomason, R A, Seymour, J S, Ellis, P J, Kelly, G, Parry, J, Dark, J R, Idle   +6 more
openaire   +2 more sources

Nitrendipine–Induced Gingival Overgrowth in Dogs

Journal of Periodontology, 1989
This study assessed the development of gingival overgrowth in dogs given nitrendipine, a new antihypertensive dihydropyridine. Nine male Beagle dogs with established plaque and gingivitis were used. Following a baseline examination, which involved assessment of plaque, gingivitis, and gingival enlargement, six dogs (test) received nitrendipine twice ...
L, Heijl, Y, Sundin
openaire   +2 more sources

Cyclosporin‐induced gingival overgrowth in children

International Journal of Paediatric Dentistry, 2005
SummaryCyclosporin is a potent immunosuppressant drug commonly used to prevent organ transplant rejection. In recent years, there has been a widening of its therapeutic use and an increase in the number of patients undergoing transplantation. Gingival overgrowth is one of several oral side‐effects of cyclosporin, with a quoted prevalence of between 8 ...
G, Wright, R R, Welbury, M T, Hosey
openaire   +2 more sources